Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Person reading the newsletter on a tablet

April E-Newsletter Now Available

Read about the 10th annual Rare Disease Day at NIH, an award-winning technology for drug development, an NCATS-Eli Lilly externship, a new strategic plan for toxicity testing, and more.


Eric Wk Sid and Taj Neaz Powell participating on a panel.

Patient Views and Hope of Research Defined 10th NIH Rare Disease Day

On March 1, 2018, patients, scientists, policymakers and others participated in the 10th annual Rare Disease Day at NIH.


John Wikswo, Ph.D., and Ronald Reiserer

NCATS Supports Award-Winning Technology for Drug Development

To address challenges in drug development, NCATS supported research on a device designed to make the pre-clinical drug testing process more efficient and reliable.


The NCATS high-throughput robotic screening system.

Tox21 Collaborators Release Strategic Plan for Chemical Testing

Leaders of the Toxicology in the 21st Century (Tox21) program have published a strategic and operational plan to address new research challenges.


NCATS staff with externship scholar

CTSA Program Scholar Learns New Approaches Through Externship

Through the NCATS-Eli Lilly externship, CTSA Program Scholar Josephine Taverna, M.D., learns new approaches to drive her research forward.


More Center News

Online Drug Discovery Training Modeules

View Assay Guidance Manual training workshop vidoes.

Scientists Attack Cancer’s Defenses

Scientists have developed a potential new approach to fighting cancer.

  • Facebook icon
  • Twitter icon
  • YouTube icon

Assay Guidance Manual

Assay Guidance Manual Cover

Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
 

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.